Stock Analysis

Private companies in Aier Eye Hospital Group Co., Ltd. (SZSE:300015) are its biggest bettors, and their bets paid off as stock gained 8.1% last week

SZSE:300015
Source: Shutterstock

Key Insights

  • Aier Eye Hospital Group's significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public
  • 53% of the business is held by the top 3 shareholders
  • 20% of Aier Eye Hospital Group is held by insiders

Every investor in Aier Eye Hospital Group Co., Ltd. (SZSE:300015) should be aware of the most powerful shareholder groups. With 34% stake, private companies possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

As a result, private companies collectively scored the highest last week as the company hit CN¥94b market cap following a 8.1% gain in the stock.

Let's take a closer look to see what the different types of shareholders can tell us about Aier Eye Hospital Group.

View our latest analysis for Aier Eye Hospital Group

ownership-breakdown
SZSE:300015 Ownership Breakdown September 24th 2024

What Does The Institutional Ownership Tell Us About Aier Eye Hospital Group?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

As you can see, institutional investors have a fair amount of stake in Aier Eye Hospital Group. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Aier Eye Hospital Group, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
SZSE:300015 Earnings and Revenue Growth September 24th 2024

Aier Eye Hospital Group is not owned by hedge funds. The company's largest shareholder is Aier Medical Investment Group Co., Ltd., with ownership of 34%. With 16% and 3.5% of the shares outstanding respectively, Bang Chen and Li Li are the second and third largest shareholders. Interestingly, the bottom two of the top three shareholders also hold the title of Top Key Executive and Vice Chairman, respectively, suggesting that these insiders have a personal stake in the company.

To make our study more interesting, we found that the top 3 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

Insider Ownership Of Aier Eye Hospital Group

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

Our information suggests that insiders maintain a significant holding in Aier Eye Hospital Group Co., Ltd.. It is very interesting to see that insiders have a meaningful CN¥19b stake in this CN¥94b business. Most would be pleased to see the board is investing alongside them. You may wish to access this free chart showing recent trading by insiders.

General Public Ownership

The general public-- including retail investors -- own 28% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

Private Company Ownership

It seems that Private Companies own 34%, of the Aier Eye Hospital Group stock. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. To that end, you should be aware of the 1 warning sign we've spotted with Aier Eye Hospital Group .

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.